RGBP-248

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRGBP-248
Drug Alias NameDiffronCtCellVaxucVAXdCellVaxIDO-gene silencing dendritic cell vaccine
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionDendritic cells modulatorsGene silencingImmunostimulants +[4] 
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic SyndromesLiver NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Western Ontario
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Western Ontario
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLiver NeoplasmsColorectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A